Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed study content with an access-block screen. The page shows the standard 403 layout and navigation, indicating restricted access to the record.
    Difference
    19%
    Check dated 2026-09-23T00:58:15.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision number on the page was updated to v3.7.0, indicating a new build of the page. The update appears to reflect backend or front-end changes rather than new study data.
    Difference
    0.0%
    Check dated 2026-09-15T23:57:18.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.6) was introduced, replacing the previous v3.6.5, indicating an update to the page or its template rather than changes to study information.
    Difference
    0.0%
    Check dated 2026-09-01T19:44:52.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.4 to v3.6.5, indicating a minor page revision. This change does not affect any study details or visible content related to the trial.
    Difference
    0.0%
    Check dated 2026-08-11T22:52:38.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.3 to v3.6.4. This represents a minor metadata update with no change to the study content shown.
    Difference
    0.0%
    Check dated 2026-07-28T15:31:29.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.6.0 to v3.6.3, indicating a small update to the study record metadata on the page. This reflects a minor revision to the page's versioning rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-30T01:12:41.000Z thumbnail image

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.